Drug profile · INN
retigabine
TROBALT
retigabine (TROBALT) is a kcnq (kv7) potassium channel opener.
EMA: withdrawn Nervous system (N03) N03AX21
Patents linked 0
Pipeline programs 1
News articles 0
Drug details — retigabine
- Class
- Nervous system (N03)
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.83
Quick answer
retigabine (TROBALT) is a kcnq (kv7) potassium channel opener.
Key facts
INN retigabine
Brand TROBALT
Mechanism KCNQ (Kv7) potassium channel opener
Target KCNQ (Kv7) potassium channel
Therapeutic class Nervous system (N03)
ATC code N03AX21
Mechanism of action
KCNQ (Kv7) potassium channel opener
Primary target: KCNQ (Kv7) potassium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| EMA | withdrawn | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is retigabine?
retigabine (TROBALT) is a kcnq (kv7) potassium channel opener.
What is the brand name for retigabine?
TROBALT is a marketed brand name for retigabine. Check FDA Drugs@FDA for the current US label holder and prescribing information.